XWAR
VOX
Market cap457mUSD
May 16, Last price
166.60PLN
1D
0.36%
1Q
16.91%
Jan 2017
782.42%
IPO
1,065.85%
Name
Voxel SA
Chart & Performance
Profile
Voxel S.A. operates a network of diagnostic imaging laboratories. Its diagnostic imaging services include magnetic resonance imaging scans, computed tomography scans, positron emission tomography, and single photon emission computed tomography. The company also provides services in the field of diagnostic imaging, teleradiology, and outsourcing; and information systems for hospitals and diagnostic centers. In addition, it deals with the implementation of projects related to the outfitting of diagnostic laboratories. The company operates through a network of 33 specialized laboratories in 21 cities in Poland. Voxel S.A. was founded in 2005 and is based in Kraków, Poland.
Valuation
Title PLN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 424,182 2.26% | 414,801 -6.29% | |||||||
Cost of revenue | 308,097 | 354,128 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 116,086 | 60,673 | |||||||
NOPBT Margin | 27.37% | 14.63% | |||||||
Operating Taxes | 20,022 | 11,295 | |||||||
Tax Rate | 17.25% | 18.62% | |||||||
NOPAT | 96,063 | 49,379 | |||||||
Net income | 74,204 67.02% | 44,428 -37.03% | |||||||
Dividends | (15,138) | (32,233) | |||||||
Dividend yield | 1.83% | 6.98% | |||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 34,113 | 34,239 | |||||||
Long-term debt | 163,748 | 159,860 | |||||||
Deferred revenue | 11,887 | 12,224 | |||||||
Other long-term liabilities | 965 | 2,704 | |||||||
Net debt | 132,543 | 159,763 | |||||||
Cash flow | |||||||||
Cash from operating activities | 118,471 | 96,200 | |||||||
CAPEX | (44,255) | (31,011) | |||||||
Cash from investing activities | (39,626) | (30,477) | |||||||
Cash from financing activities | (47,885) | (86,697) | |||||||
FCF | 82,147 | 47,290 | |||||||
Balance | |||||||||
Cash | 70,362 | 39,160 | |||||||
Long term investments | (5,043) | (4,824) | |||||||
Excess cash | 44,109 | 13,596 | |||||||
Stockholders' equity | 206,547 | 155,054 | |||||||
Invested Capital | 391,276 | 381,081 | |||||||
ROIC | 24.88% | 13.17% | |||||||
ROCE | 25.75% | 14.87% | |||||||
EV | |||||||||
Common stock shares outstanding | 10,503 | 10,503 | |||||||
Price | 78.60 78.64% | 44.00 -3.30% | |||||||
Market cap | 825,504 78.64% | 462,114 -3.30% | |||||||
EV | 960,141 | 623,892 | |||||||
EBITDA | 154,802 | 98,752 | |||||||
EV/EBITDA | 6.20 | 6.32 | |||||||
Interest | 10,541 | 10,612 | |||||||
Interest/NOPBT | 9.08% | 17.49% |